Literature DB >> 19084598

Interferon-gamma increases expression of the di/tri-peptide transporter, h-PEPT1, and dipeptide transport in cultured human intestinal monolayers.

David R Foster1, Christopher P Landowski, Xiaomei Zheng, Gordon L Amidon, Lynda S Welage.   

Abstract

The di/tri-peptide transporter h-PEPT1 plays an important role in the oral absorption of di/tri-peptides and numerous drugs. Inflammatory conditions may influence intestinal xenobiotic transporter function; however, the effects of inflammation on h-PEPT1 have not been well described. This study was conducted to determine the effects of the inflammatory cytokine interferon-gamma (IFN-gamma) on h-PEPT1 mediated dipeptide absorption. Caco-2 monolayers were grown on permeable supports. The effective apical-to-basolateral permeability (P(eff)) of glycylsarcosine (Gly-Sar) was measured following incubation with IFN-gamma or control media. Additional experiments were conducted at 4 degrees C, and with escalating concentrations of Gly-Sar. h-PEPT1 expression was determined using semiquantitative RT-PCR. IFN-gamma 50 ng/ml increased Gly-Sar P(eff) 28.6% compared to controls (p=0.03). In experiments conducted at 4 degrees C, Gly-Sar P(eff) decreased 39.6% in IFN-gamma treated cells (p=0.003) and 28.4% in controls (p=0.006). In controls and IFN-gamma treated cells, concentration dependent transport was seen with escalating concentrations of Gly-Sar. Compared to controls, IFN-gamma 50 and 100 ng/ml increased h-PEPT1 mRNA expression by 14.2% and 11.5%, respectively (p=0.019). In summary, IFN-gamma increases h-PEPT1 expression and permeation of the dipeptide Gly-Sar in Caco-2 monolayers. These findings imply that intestinal absorption of peptides and peptidomimetic drugs may be increased in certain inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19084598     DOI: 10.1016/j.phrs.2008.11.001

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

Review 1.  Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.

Authors:  Emilie Viennois; Adani Pujada; Jane Zen; Didier Merlin
Journal:  Compr Physiol       Date:  2018-03-25       Impact factor: 9.090

Review 2.  The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease.

Authors:  Sarah A Ingersoll; Saravanan Ayyadurai; Moiz A Charania; Hamed Laroui; Yutao Yan; Didier Merlin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-22       Impact factor: 4.052

3.  Differentiating passive from transporter-mediated uptake by PepT1: a comparison and evaluation of four methods.

Authors:  Jeffrey S Scow; Srivats Madhavan; Rizwan M Chaudhry; Ye Zheng; Judith A Duenes; Michael G Sarr
Journal:  J Surg Res       Date:  2011-03-12       Impact factor: 2.192

4.  Expression and regulation of the proton-coupled oligopeptide transporter PhT2 by LPS in macrophages and mouse spleen.

Authors:  Yuqing Wang; Dongli Sun; Feifeng Song; Yongjun Hu; David E Smith; Huidi Jiang
Journal:  Mol Pharm       Date:  2014-05-02       Impact factor: 4.939

Review 5.  Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers.

Authors:  Vladimir Khavinson; Natalia Linkova; Ekaterina Kozhevnikova; Anastasiia Dyatlova; Mikhael Petukhov
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.